Header Logo

Connection

Alan Rosmarin to Cell Line

This is a "connection" page, showing publications Alan Rosmarin has written about Cell Line.
Connection Strength

0.206
  1. Yang ZF, Mott S, Rosmarin AG. The Ets transcription factor GABP is required for cell-cycle progression. Nat Cell Biol. 2007 Mar; 9(3):339-46.
    View in: PubMed
    Score: 0.050
  2. Resendes KK, Rosmarin AG. GA-binding protein and p300 are essential components of a retinoic acid-induced enhanceosome in myeloid cells. Mol Cell Biol. 2006 Apr; 26(8):3060-70.
    View in: PubMed
    Score: 0.047
  3. Rosmarin AG, Luo M, Caprio DG, Shang J, Simkevich CP. Sp1 cooperates with the ets transcription factor, GABP, to activate the CD18 (beta2 leukocyte integrin) promoter. J Biol Chem. 1998 May 22; 273(21):13097-103.
    View in: PubMed
    Score: 0.027
  4. Rosmarin AG, Caprio DG, Kirsch DG, Handa H, Simkevich CP. GABP and PU.1 compete for binding, yet cooperate to increase CD18 (beta 2 leukocyte integrin) transcription. J Biol Chem. 1995 Oct 06; 270(40):23627-33.
    View in: PubMed
    Score: 0.023
  5. Rosmarin AG, Caprio D, Levy R, Simkevich C. CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci U S A. 1995 Jan 31; 92(3):801-5.
    View in: PubMed
    Score: 0.022
  6. Rosmarin AG, Levy R, Tenen DG. Cloning and analysis of the CD18 promoter. Blood. 1992 May 15; 79(10):2598-604.
    View in: PubMed
    Score: 0.018
  7. Rosmarin AG, Weil SC, Rosner GL, Griffin JD, Arnaout MA, Tenen DG. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood. 1989 Jan; 73(1):131-6.
    View in: PubMed
    Score: 0.014
  8. Pahl HL, Rosmarin AG, Tenen DG. Characterization of the myeloid-specific CD11b promoter. Blood. 1992 Feb 15; 79(4):865-70.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.